PACT-Impact-Report--header---EN

WFH PACT Program 2022 Impact Report: now available online

The WFH Path to Access to Care and Treatment (PACT) Program is a 5-year initiative designed to improve outreach and diagnosis and increase access to sustainable care for people with inherited bleeding disorders. In a short time, the Program has had measurable impacts on the bleeding disorders communities in the countries where it’s active. These impacts have been documented in the WFH PACT Program 2022 Impact Report, now available online.

Also available in: Français Español

The WFH PACT Program was launched in 2021 and is active in twenty countries worldwide. Each country is responsible for developing a national access plan that includes personalized training, outreach, and advocacy components to increase support from national governments for bleeding disorders programs. Today, as we are at the midpoint of this five-year global initiative, we are happy to share that in two years, the Program has contributed to a notable increase in the level of care in the target countries.

The PACT Program helps us identify new patients in the country. After seeing the numbers of diagnosed PWBDs, our government expressed willingness to begin purchasing treatment products. We are now in the preliminary stages of discussion to pursue this endeavor with our government.

—Megan Buckie Adediran, Hemophilia Foundation of Nigeria, Nigeria

Some of the achievements covered in the report include the following:

To find out more about what the Program has done around the world—and to read some inspirational case studies—please view the report here.

To learn more about the WFH Path to Access to Care and Treatment (PACT) Program, please click here.

The PACT Program is supported by funding from Roche and Sanofi, our visionary partners; CSL Behring and Pfizer, our leadership partners; and Bayer, Biotest and Grifols, our collaborating partners.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.